BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/19/2018 7:56:07 AM | Browse: 1555 | Download: 2433
 |
Received |
|
2018-01-03 21:08 |
|
Peer-Review Started |
|
2018-01-04 06:08 |
|
First Decision by Editorial Office Director |
|
2018-01-16 19:57 |
|
Return for Revision |
|
2018-01-18 02:35 |
|
Revised |
|
2018-03-10 12:43 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2018-03-22 08:00 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2018-03-25 16:38 |
|
Articles in Press |
|
2018-03-25 16:38 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2018-04-18 06:04 |
|
Publish the Manuscript Online |
|
2018-04-19 07:56 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Analysis of aggressiveness factors in hepatocellular carcinoma patients undergoing transarterial chemoembolization
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Yossi Ventura, Brian I Carr, Issac Kori, Vito Guerra and Oren Shibolet |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Oren Shibolet, FRCP (C), MD, PhD, Academic Research, Chief Doctor, Professor, Senior Lecturer, Department of Gastroenterology and Liver Disease, Tel-Aviv Medical Center and the Sackler Faculty of Medicine, Shibolet, O (reprint author), Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Gastroenterol, Liver Unit, IL-69978 Tel Aviv, Israel., Tel-Aviv University, Liver Unit, Department of Gastroenterology and Liver Disease, Tel-Aviv Medical Center and the Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel. weizman 6 orensh@tlvmc.gov.il., Tel aviv 6423906, Israel. orensh@tlvmc.gov.il |
| Key Words |
Hepatocellular carcinoma; Aggressiveness index; Liver function; Transarterial chemoembolization; Survival |
| Core Tip |
Our cohort’s population included patients with multiple underlying liver diseases and can be widely generalized. The aggressiveness index (AgI) was correlated with survival. AgI > 4 was associated with decreased survival. Combining the AgI with elevated GGTP and ALKP levels improved its prognostic yield in our patient population. We validated the AgI as a prognostic tool to predict overall survival in a novel population of hepatocellular carcinoma patients undergoing transarterial chemoembolization. |
| Publish Date |
2018-04-19 07:56 |
| Citation |
Ventura Y, Carr BI, Kori I, Guerra V, Shibolet O. Analysis of aggressiveness factors in hepatocellular carcinoma patients undergoing transarterial chemoembolization. World J Gastroenterol 2018; 24(15): 1641-1649
|
| URL |
http://www.wjgnet.com/1007-9327/full/v24/i15/1641.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v24.i15.1641 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.
